Cargando…

Regulation of low-density lipoprotein receptor expression in triple negative breast cancer by EGFR-MAPK signaling

Expression of the low-density lipoprotein receptor (LDLR) has been shown to play a critical role in hypercholesterolemia-associated breast cancer growth and is associated with shorter recurrence-free survival in human breast cancer studies. We sought to identify how circulating LDL cholesterol and t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scully, Tiffany, Kase, Nathan, Gallagher, Emily J., LeRoith, Derek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429745/ https://www.ncbi.nlm.nih.gov/pubmed/34504181 http://dx.doi.org/10.1038/s41598-021-97327-y

Ejemplares similares

SAT-151 Regulation of Low-Density Lipoprotein Receptor Expression in Triple Negative Breast Cancer
por: Scully, Tiffany, et al.
Publicado: (2020)

OR16-05 25-Hydroxycholesterol Mediates The Effects Of Dyslipidemia On Triple Negative Breast Cancer Metastasis
por: Etella, Abora, et al.
Publicado: (2023)

SUN-131 The Roles of Two Insulin Receptor Isoforms in Triple Negative Breast Cancer Growth
por: Kang, Chifei, et al.
Publicado: (2020)

Obesity, Type 2 Diabetes, and Cancer Risk
por: Scully, Tiffany, et al.
Publicado: (2021)

Epidemiology and Molecular Mechanisms Tying Obesity, Diabetes, and the Metabolic Syndrome With Cancer
por: Gallagher, Emily J., et al.
Publicado: (2013)

Elevated tumor LDLR expression accelerates LDL cholesterol-mediated breast cancer growth in mouse models of hyperlipidemia
por: Gallagher, Emily J., et al.
Publicado: (2017)

Hyperinsulinemia promotes aberrant histone acetylation in triple-negative breast cancer
por: Senapati, Parijat, et al.
Publicado: (2019)

TMEM176B Regulates AKT/mTOR Signaling and Tumor Growth in Triple-Negative Breast Cancer
por: Kang, Chifei, et al.
Publicado: (2021)

SAT-137 The Effect of Hypertriglyceridemia on Triple Negative Breast Cancer Progression
por: Scully, Tiffany, et al.
Publicado: (2020)

Expression and clinical significance of MAPK and EGFR in triple-negative breast cancer
por: Jiang, Weihua, et al.
Publicado: (2020)

Hallmarks of cancer: The insulin-like growth factors perspective
por: Werner, Haim, et al.
Publicado: (2022)

Inhibiting PI3K reduces mammary tumor growth and induces hyperglycemia in a mouse model of insulin resistance and hyperinsulinemia
por: Gallagher, Emily Jane, et al.
Publicado: (2011)

Multi-Tissue Computational Modeling Analyzes Pathophysiology of Type 2 Diabetes in MKR Mice
por: Kumar, Amit, et al.
Publicado: (2014)

Differential Effects of Insulin and IGF1 Receptors on ERK and AKT Subcellular Distribution in Breast Cancer Cells
por: Sarfstein, Rive, et al.
Publicado: (2019)

The Intricate Role of Growth Hormone in Metabolism
por: Vijayakumar, Archana, et al.
Publicado: (2011)

Editorial: What's New in Endocrinology?
por: Holly, Jeff M. P., et al.
Publicado: (2019)

Insulin-like growth factors: Ligands, binding proteins, and receptors
por: LeRoith, Derek, et al.
Publicado: (2021)

The Link between the Metabolic Syndrome and Cancer
por: Braun, Sandra, et al.
Publicado: (2011)

Insulin Receptor Phosphorylation by Endogenous Insulin or the Insulin Analog AspB10 Promotes Mammary Tumor Growth Independent of the IGF-I Receptor
por: Gallagher, Emily Jane, et al.
Publicado: (2013)

Assessing the association of diabetes with lung cancer risk
por: Leiter, Amanda, et al.
Publicado: (2021)

The Role of Insulin and Insulin-like Growth Factors in the Increased Risk of Cancer in Diabetes
por: LeRoith, Derek, et al.
Publicado: (2011)

Insulin-like Growth Factor 1 Signaling Axis Meets p53 Genome Protection Pathways
por: Werner, Haim, et al.
Publicado: (2016)

Silencing Vimentin Expression Decreases Pulmonary Metastases in a Pre-Diabetic Mouse Model of Mammary Tumor Progression
por: Zelenko, Zara, et al.
Publicado: (2016)

Insulin’s Role in Diabetes Management: After 90 Years, Still Considered the Essential “Black Dress”
por: Cefalu, William T., et al.
Publicado: (2015)

Deep sequencing of mRNA in CD24(−) and CD24(+) mammary carcinoma Mvt1 cell line
por: Rostoker, Ran, et al.
Publicado: (2015)

Insulin-Sensitizing Therapy Attenuates Type 2 Diabetes–Mediated Mammary Tumor Progression
por: Fierz, Yvonne, et al.
Publicado: (2010)

High-Efficient FLPo Deleter Mice in C57BL/6J Background
por: Wu, Yingjie, et al.
Publicado: (2009)

Interplay of Low-Density Lipoprotein Receptors, LRPs, and Lipoproteins in Pulmonary Hypertension
por: Calvier, Laurent, et al.
Publicado: (2022)

Targeting EGFR in Triple Negative Breast Cancer
por: Ueno, Naoto T., et al.
Publicado: (2011)

Nanoparticles with High-Surface Negative-Charge Density Disturb the Metabolism of Low-Density Lipoprotein in Cells
por: Bai, Xue, et al.
Publicado: (2018)

The influence of triglycerides on small dense low‐density lipoprotein cholesterol levels is attenuated in low low‐density lipoprotein‐cholesterol range: Implications for the negative results of the PROMINENT trial
por: Hirano, Tsutomu, et al.
Publicado: (2023)

Intracerebroventricular Leptin Infusion Improves Glucose Homeostasis in Lean Type 2 Diabetic MKR Mice via Hepatic Vagal and Non-Vagal Mechanisms
por: Li, Xiaosong, et al.
Publicado: (2011)

Getting to the “Heart” of the Matter on Diabetic Cardiovascular Disease: “Thanks for the Memory”
por: Cefalu, William T., et al.
Publicado: (2016)

Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)
por: Katsiki, Niki, et al.
Publicado: (2023)

Impact of diabetes on stage I lung cancer treatment patterns and prognosis in older adults: A population-based cohort study
por: Leiter, Amanda, et al.
Publicado: (2023)

Lenvatinib- and vadimezan-loaded synthetic high-density lipoprotein for combinational immunochemotherapy of metastatic triple-negative breast cancer
por: Zheng, Chao, et al.
Publicado: (2022)

Negative Regulation of EGFR/MAPK Pathway by Pumilio in Drosophila melanogaster
por: Kim, Sung Yun, et al.
Publicado: (2012)

GLUT4-overexpressing engineered muscle constructs as a therapeutic platform to normalize glycemia in diabetic mice
por: Beckerman, Margarita, et al.
Publicado: (2021)

CD24 cell surface expression in Mvt1 mammary cancer cells serves as a biomarker for sensitivity to anti-IGF1R therapy
por: Rostoker, Ran, et al.
Publicado: (2016)

Regulatory T Cells in Arterivirus and Coronavirus Infections: Do They Protect Against Disease or Enhance it?
por: Cecere, Thomas E., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_7phhb6bkf0uf0oibqvif751vur